BioLoomics is a preclinical stage biotechnology company pioneering directed evolution of target degrading antibodies using human cells
BioLoomics is a preclinical stage biotechnology company pioneering directed evolution of target degrading antibodies using human cells. The company utilizes a mixture of synthetic biology and computer vision guided cell picking to navigate through antibody design space.
BioLoomics is a preclinical stage biotechnology company pioneering directed evolution of target degrading antibodies using human cells
BioLoomics is a preclinical stage biotechnology company pioneering directed evolution of target degrading antibodies using human cells. The company utilizes a mixture of synthetic biology and computer vision guided cell picking to navigate through antibody design space.